G. E. Carpagnano, “Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management”, Multidiscip Respir Med, vol. 17, Feb. 2022, doi: 10.4081/mrm.2022.797.